Pfizer asked the U.S. government on Oct. 7 to allow use of its COVID-19 vaccine in children ages 5 to 11 – and if regulators agree, shots could begin within a matter of weeks.
Search / 13 results found Showing: 1-10 of 13
The U.S. gave full approval to Pfizer’s COVID-19 vaccine on Aug. 23, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet.
Pfizer announces that the vaccine is safe and strongly protective in kids as young as 12.
Although AstraZeneca’s vaccine has been authorized in more than 50 countries, it has not yet been given the green light in the United States.
The Pfizer and Moderna vaccines are “very effective,” but there is limited availability and, in the case of Pfizer, logistical challenges presented by ultra-cold storage needs.
The first home test for COVID-19 that doesn't require a prescription will soon be on U.S. store shelves.
The largest vaccination campaign in U.S. history got underway on Dec. 4.
(AP) -- Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection � ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.